HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Martin S Tallman Selected Research

Aligeron (AS 2)

11/2010Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
9/2010Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.
5/2008Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
1/2008Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
11/2006Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Martin S Tallman Research Topics

Disease

58Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2015 - 03/2002
41Acute Promyelocytic Leukemia
11/2015 - 01/2002
31Leukemia
03/2015 - 04/2002
16Neoplasms (Cancer)
11/2015 - 09/2004
14Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2014 - 10/2002
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014 - 08/2002
12B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2015 - 10/2002
8Hairy Cell Leukemia
10/2015 - 04/2002
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2009 - 10/2002
6Breast Neoplasms (Breast Cancer)
08/2011 - 07/2003
5Hematologic Neoplasms (Hematological Malignancy)
11/2015 - 01/2002
5Thrombocytopenia (Thrombopenia)
02/2009 - 06/2002
4Residual Neoplasm
07/2014 - 04/2003
4Philadelphia Chromosome
02/2014 - 10/2002
4Anemia
11/2012 - 11/2005
4Infection
05/2012 - 08/2002
4Drug Toxicity (Drug Safety)
06/2009 - 11/2005
3Hemorrhage
09/2013 - 03/2005
3Kidney Diseases (Kidney Disease)
11/2012 - 09/2004
3Leukocytosis (Pleocytosis)
12/2009 - 04/2005
2Graft vs Host Disease (Graft-Versus-Host Disease)
10/2015 - 07/2010
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2014 - 12/2013
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2013 - 05/2007
2Disease Progression
03/2013 - 05/2012
2Thrombosis (Thrombus)
09/2012 - 06/2007
2Chromosome Aberrations (Chromosome Abnormalities)
09/2012 - 09/2012
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012 - 04/2009
2Disseminated Intravascular Coagulation
03/2009 - 06/2007
2Neutropenia
06/2007 - 02/2007
2Pure Red-Cell Aplasia
11/2005 - 09/2004
2Myeloid Leukemia (Leukemia, Myelocytic)
09/2004 - 04/2004
1Aplastic Anemia (Anemia, Hypoplastic)
10/2015

Drug/Important Bio-Agent (IBA)

27Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2015 - 10/2002
15arsenic trioxide (Trisenox)FDA Link
07/2014 - 01/2002
11Cytarabine (Cytosar-U)FDA LinkGeneric
07/2015 - 08/2002
10Phosphotransferases (Kinase)IBA
12/2013 - 08/2003
9gemtuzumab (gemtuzumab ozogamicin)FDA Link
06/2013 - 03/2002
8imatinib (Gleevec)FDA Link
02/2014 - 10/2002
6DNA (Deoxyribonucleic Acid)IBA
12/2014 - 10/2009
6ErythropoietinFDA Link
11/2012 - 10/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 07/2003
5fludarabineIBA
11/2015 - 05/2004
5purineIBA
10/2015 - 10/2002
5Daunorubicin (Cerubidine)FDA LinkGeneric
07/2015 - 01/2003
5Aligeron (AS 2)IBA
11/2010 - 11/2006
4rituximab (Mabthera)FDA Link
02/2015 - 10/2002
4alemtuzumab (Campath)FDA Link
02/2015 - 10/2002
4Azacitidine (5 Azacytidine)FDA Link
10/2014 - 10/2009
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 - 01/2004
3Proteins (Proteins, Gene)IBA
07/2015 - 08/2003
3Asparaginase (Elspar)FDA Link
03/2014 - 01/2003
3CladribineFDA LinkGeneric
06/2011 - 05/2004
3Prednisone (Sone)FDA LinkGeneric
11/2010 - 01/2003
3Eukaryotic Initiation Factor-4EIBA
10/2010 - 02/2005
3ArsenicIBA
09/2010 - 07/2008
3Immunoconjugates (Immunoconjugate)IBA
10/2009 - 10/2002
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2009 - 02/2007
3Sirolimus (Rapamycin)FDA Link
01/2008 - 10/2005
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2007 - 01/2004
3Monoclonal AntibodiesIBA
10/2006 - 10/2002
2fms-Like Tyrosine Kinase 3IBA
12/2014 - 01/2013
2Histones (Histone)IBA
10/2014 - 08/2006
2N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
04/2014 - 10/2009
2Farnesyltranstransferase (Farnesyltransferase)IBA
03/2014 - 10/2002
2alpha-hydroxyglutarateIBA
06/2013 - 12/2010
2tebufenozide (Mimic)IBA
01/2013 - 06/2002
2HematinicsIBA
11/2012 - 02/2008
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2012 - 02/2008
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2012 - 03/2004
2Etoposide (VP 16)FDA LinkGeneric
04/2012 - 03/2004
2CaspasesIBA
10/2011 - 10/2009
2AEG 35156IBA
10/2011 - 10/2009
2X-Linked Inhibitor of Apoptosis ProteinIBA
10/2011 - 10/2009
2Protein Kinases (Protein Kinase)IBA
10/2010 - 10/2005
2Estrogens (Estrogen)FDA Link
01/2010 - 05/2009
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
10/2009 - 08/2002
2ExotoxinsIBA
10/2009 - 10/2002
2retinoic acid receptor alphaIBA
07/2008 - 04/2003
2AnthracyclinesIBA
01/2008 - 08/2002
2AntibodiesIBA
11/2005 - 01/2005
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
10/2005 - 02/2005
2Interferon-alpha (Interferon Alfa)FDA Link
10/2005 - 05/2005
2valspodar (PSC 833)IBA
08/2004 - 03/2004
2InterferonsIBA
06/2003 - 04/2002
1Protein Isoforms (Isoforms)IBA
11/2015
1RNA (Ribonucleic Acid)IBA
11/2015
1Methotrexate (Mexate)FDA LinkGeneric
10/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2015
1Tacrolimus (Prograf)FDA LinkGeneric
10/2015
1Inhibitor of Apoptosis ProteinsIBA
07/2015
1malic acid (malate)IBA
04/2015

Therapy/Procedure

47Drug Therapy (Chemotherapy)
11/2015 - 06/2002
10Hematopoietic Stem Cell Transplantation
07/2013 - 07/2003
9Transplants (Transplant)
10/2015 - 02/2006
7Transplantation (Transplant Recipients)
10/2015 - 07/2003
6Cell Transplantation
10/2015 - 02/2008
5Homologous Transplantation (Allograft)
10/2015 - 02/2008
3Autologous Transplantation
05/2011 - 02/2008
3Adjuvant Chemotherapy
01/2010 - 07/2003
1Aftercare (After-Treatment)
10/2015